MiR-1261/circ-PTPRZ1/PAK1 pathway regulates glioma cell growth and invasion.

Human Cell
Feng ZhangLiang Zhang

Abstract

Glioma is the most common primary brain tumor in adults, with high malignancy and poor prognosis. According to the research in these years, the relationship between circular RNAs (circRNAs) and glioma development is abnormally close. Studies on circRNAs in glioma cells revealed that miR-1261 had almost completely matched binding site on the circ-PTPRZ1 sequence, and dual-luciferase reporter gene assay confirmed that circ-PTPRZ1 was a target gene of miR-1261. MiR-1261 inhibited circ-PTPRZ1 expression in glioma cells, while circ-PTPRZ1 did not affect miR-1261 expression. At the same time, circ-PTPRZ1 could promote p-PAK1 expression, while miR-1261 suppressed the activation of PAK1 by regulating the expression of circ-PTPRZ1. Biological behaviors of glioma cells were detected, circ-PTPRZ1 enhanced cell proliferation and invasion, and inhibited cell apoptosis; miR-1261 had the opposite effects, and could terminate the above effects of circ-PTPRZ1. When co-transfected with PAK1 siRNAs and circ-PTPRZ1 over-expression vector, the changes of above biological behaviors were not obvious. Therefore, in glioma cells, the expression of circ-PTPRZ1/PAK1 is regulated by miR-1261, which affects the proliferation, apoptosis, and invasion. This ...Continue Reading

References

Nov 17, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hiroshi AokiYasuko Kondo
Jun 8, 2010·Clinical & Experimental Metastasis·Liangping YuanTobey J MacDonald
Apr 3, 2012·Drug Discoveries & Therapeutics·H Maruta
Sep 10, 2013·Cancer Research·Thomas B HansenChristian K Damgaard
Jul 15, 2015·Biochimica Et Biophysica Acta·Karoline K EbbesenThomas B Hansen
Oct 16, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Jin-Hua HeJing-Zhi Zhang
Dec 23, 2016·Gene·Rakesh KumarFeng Li
Feb 17, 2017·Biochemical Society Transactions·Galina Semenova, Jonathan Chernoff
Sep 15, 2017·Journal of the National Cancer Institute·Yibing YangNu Zhang
Jan 14, 2018·Seminars in Cancer Biology·Chetan K Rane, Audrey Minden
Apr 25, 2018·Journal of Clinical Laboratory Analysis·Jinxu ZhouYuhai Wang
Jun 20, 2018·Clinical Neurology and Neurosurgery·Hong-Xiang WangJu-Xiang Chen
Sep 28, 2018·Advances in Experimental Medicine and Biology·Rupal OjhaVijay Kumar Prajapati
Oct 18, 2018·Clinical and Translational Medicine·Debarati GhoshSonali Bhattacharjee
Jan 9, 2019·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal

❮ Previous
Next ❯

Citations

Apr 23, 2020·International Journal of Molecular Medicine·Yu Zhang, Hongyan Zhou
May 7, 2021·International Journal of Biological Macromolecules·Milad AshrafizadehMichael R Hamblin

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
PCR
protein assay
enzyme linked immunosorbent assay
flow cytometry

Software Mentioned

SPSS17

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis